Your browser doesn't support javascript.
loading
Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents and venetoclax.
Apolito, Vincenzo; Arrigo, Giulia; Vasseur, Loic; Olivi, Matteo; Perrone, Silvia; Giai, Valentina; Secreto, Carolina; Di Biase, Federica; De Simone, Maria Carla; Copia, Carolina; Gravetti, Angela; Freilone, Roberto; Bruno, Benedetto; Lanzarone, Giuseppe; Beggiato, Eloise; Frairia, Chiara; Audisio, Ernesta; D'Ardia, Stefano; Ferrero, Dario; Cerrano, Marco; Ferrara, Felicetto.
Affiliation
  • Apolito V; Division of Haematology, University of Turin, Turin, Italy.
  • Arrigo G; Pediatric Oncohematology, Stem Cell Transplantation and Cell Therapy Division, Regina Margherita Children's Hospital, Turin, Italy.
  • Vasseur L; Division of Haematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
  • Olivi M; Hôpital Saint-Louis, Assistance, Publique-Hôpitaux de Paris, Paris, France.
  • Perrone S; Division of Haematology, University of Turin, Turin, Italy.
  • Giai V; Division of Haematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
  • Secreto C; Division of Haematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
  • Di Biase F; Division of Haematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
  • De Simone MC; Division of Haematology, University of Turin, Turin, Italy.
  • Copia C; Division of Haematology, AORN Cardarelli, Naples, Italy.
  • Gravetti A; Division of Haematology, AORN Cardarelli, Naples, Italy.
  • Freilone R; Division of Haematology, AORN Cardarelli, Naples, Italy.
  • Bruno B; Division of Haematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
  • Lanzarone G; Division of Haematology, University of Turin, Turin, Italy.
  • Beggiato E; Division of Haematology, University of Turin, Turin, Italy.
  • Frairia C; Division of Haematology, University of Turin, Turin, Italy.
  • Audisio E; Division of Haematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
  • D'Ardia S; Division of Haematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
  • Ferrero D; Division of Haematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
  • Cerrano M; Division of Haematology, University of Turin, Turin, Italy.
  • Ferrara F; Division of Haematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
Br J Haematol ; 203(4): e98-e101, 2023 11.
Article in En | MEDLINE | ID: mdl-37533098

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Br J Haematol Year: 2023 Document type: Article Affiliation country: Italia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Br J Haematol Year: 2023 Document type: Article Affiliation country: Italia